Also categorized in Global Health:
Caffeine May Offset Some Health Risks of Diets High in Fat, Sugar
x hide permanently

Targeting Plasmacytoid Dendritic Cells Can Reduce Cutaneous Lupus Symptoms

EurekAlert! Science News Releases

Photo: Pixabay

eurekalert.org

Jodi Karnell and colleagues have developed a monoclonal antibody, VIB7734, that reduces symptom severity in people with cutaneous lupus by targeting and depleting plasmacytoid dendritic cells (pDC) in blood and skin. In two phase I clinical trials involving a total of 67 people with autoimmune diseases such as lupus, treatment with VIB7734 was as safe as a placebo and significantly reduced pDC frequencies, the researchers found. The antibody also reduced the activity of a group of key immune proteins called type 1 interferons in the skin. Both pDCs and type 1 interferons are suspected to play ...